Tony's Diary Package — page 850

niaid.nih.gov> S.2ZOV C/OD) <aux7 @cdc.gov>; Levine, Rachel (HHS/OASH) alla (OS/ASPR/IO) (CTR) <Marcella.Nunez3.Phillips@hhs.gov>; Perry, Sherice (OS/IEA) curve by a few weeks at the time you realize you were behind the curve. I use the analogy of skating to where the puck will be not where it is now . In this regard, there will be criticisms that we acted too soon particularly since so many people around the world have not yet received any vaccine. This is countered by the fact that the United states is doing more than the rest of the world combined to get vaccine to lower middle income countries. There is an additional complicating issue here in that Jeff is insisting that when we announced this, it looks like it is a done deal and we are definitely going to do this . However, it really does depend on or authorization from the FDA together with recommendation from the CDC via advice from the ACIP. If we come out and definitively say we're going to do it prior to the FDA approval , it looks like we have politically influencing the FDA. I am warning Jeff about this because even though he is trying to do the right thing , we have to be careful that we don't look like we are tipping the scales and overriding the FDA. Janet Woodcock is very concerned about this and I do not blame her. Another complicating issue is that last night someone leaked our plan to the press and although we are going to make the announcement tomorrow the press is running wild with speculations and partial data right now. I have not answered any press calls because I do not want to get involved invalidating the breaking of a very strict code of silence. Shame on the person or persons who leaked this period now we have to explain things without necessarily giving everybody all the necessary information. In addition , we have faced with the usual problem of the CDC not giving us all the information that we need and even continuing to refer two embargoed MMWR papers to come out. We absolutely need to see those data if we are going to defend our policy. Email that I sent to Ian Sams: From: Fauci, Anthony (NIH/NIAID) [E] <afauci@niaid.nih.gov> Sent: Tuesday, August 17, 2021 2:02 PM To: Sams, Ian (HHS/ASPA) <Ian.Sams@hhs.gov>; Kessler, David (HHS/IOS) <David.Kessler@hhs.gov>; Murthy, Vivek (HHS/OASH) <Vivek.Murthy@hhs.gov>; Collins, Francis (NIH/OD) [E] <collinsf@od.nih.gov>; Walensky, Rochelle (CDC/OD) <aux7@cdc.gov>; Levine, Rachel (HHS/OASH) <Rachel.Levine@hhs.gov>; Nunez-Smith, Marcella (OS/ASPR/IO) (CTR) <Marcella.NunezSmith@hhs.gov> Cc: Phillips, Alexandria (HHS/OASH) <Alexandria.Phillips@hhs.gov>; Perry, Sherice (OS/IEA) <Sherice.Perry@hhs.gov> Subject: RE: Latest statement + Tough QA Thanks, Ian. The following that is in the statement is a very important part of the statement. Please make sure that it does not disappear. "...once FDA conducts an independent evaluation and